From Casetext: Smarter Legal Research

Cephalon, Inc. v. Watson Pharms., Inc.

United States Court of Appeals for the federal Circuit
Mar 29, 2012
2011-1325 (Fed. Cir. Mar. 29, 2012)

Opinion

2011-1325

03-29-2012

CEPHALON, INC. and CIMA LABS, INC., Plaintiffs-Appellants, v. WATSON PHARMACEUTICALS, INC., WATSON LABORATORIES, INC., and WATSON PHARMA, INC., Defendants-Appellees.


NOTE: This order is nonprecedential.


Appeal from the United States District Court for the District of Delaware in case no. 08-CV-0330, Judge Sue L. Robinson.

ON MOTION


ORDER

Watson Pharmaceuticals, Inc., Watson Laboratories, Inc., and Watson Pharma, Inc., move for a 30-day extension of time, until May 4, 2012, to file their opening brief due to settlement negotiations.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is granted. No further extensions should be anticipated.

FOR THE COURT

______________

Jan Horbaly

Clerk
cc: William F. Lee, Esq.

James K. Stronski, Esq.
s21


Summaries of

Cephalon, Inc. v. Watson Pharms., Inc.

United States Court of Appeals for the federal Circuit
Mar 29, 2012
2011-1325 (Fed. Cir. Mar. 29, 2012)
Case details for

Cephalon, Inc. v. Watson Pharms., Inc.

Case Details

Full title:CEPHALON, INC. and CIMA LABS, INC., Plaintiffs-Appellants, v. WATSON…

Court:United States Court of Appeals for the federal Circuit

Date published: Mar 29, 2012

Citations

2011-1325 (Fed. Cir. Mar. 29, 2012)